The Impact of the COVID-19 Pandemic on Bariatric Surgery: Results from a Worldwide Survey.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
11 2020
Historique:
received: 12 05 2020
accepted: 25 06 2020
revised: 25 06 2020
pubmed: 13 7 2020
medline: 10 10 2020
entrez: 13 7 2020
Statut: ppublish

Résumé

The ongoing "coronavirus disease 19" (COVID-19) pandemic has had a strong effect on the delivery of surgical care worldwide. Elective surgeries have been canceled or delayed in order to reallocate resources to the treatment of COVID-19 patients. Currently, the impact of the COVID-19 pandemic on bariatric and metabolic surgical practice remains unclear. An internet-based online survey was performed among bariatric surgeons worldwide. The survey was sent to bariatric surgeons via the International Bariatric Club Facebook group and by electronic mail via the International Federation for the Surgery of Obesity and metabolic disorders (IFSO) secretariat to members of the associated national IFSO societies. One hundred sixty-nine (n = 169) bariatric surgeons participated in the survey. The majority of the respondents postponed preoperative upper gastrointestinal tract endoscopies, appointments in the outpatient clinic and bariatric operations. Most surgeons performed video calls for follow-up appointments instead of meeting the patients in the outpatient clinics. Laparoscopy was still the preferred treatment for surgical emergencies, but a trend towards conservative treatment of acute appendicitis and acute cholecystitis was shown. Rapid preoperative COVID-19 testing availability was poor; therefore, routine screening of emergency bariatric cases was not widely provided. A wide variance occurred regarding precautions and personal protection equipment among the participants. The COVID-19 pandemic showed a strong impact on bariatric surgical practice regarding surgical and outpatient planning as well as personnel management. Coordinated effort from the national bariatric societies should focus on strict implementation of the current recommendations regarding precaution measures and personal protection equipment. Further studies should evaluate how this impact will evolve in the near future.

Sections du résumé

BACKGROUND
The ongoing "coronavirus disease 19" (COVID-19) pandemic has had a strong effect on the delivery of surgical care worldwide. Elective surgeries have been canceled or delayed in order to reallocate resources to the treatment of COVID-19 patients. Currently, the impact of the COVID-19 pandemic on bariatric and metabolic surgical practice remains unclear.
METHODS
An internet-based online survey was performed among bariatric surgeons worldwide. The survey was sent to bariatric surgeons via the International Bariatric Club Facebook group and by electronic mail via the International Federation for the Surgery of Obesity and metabolic disorders (IFSO) secretariat to members of the associated national IFSO societies.
RESULTS
One hundred sixty-nine (n = 169) bariatric surgeons participated in the survey. The majority of the respondents postponed preoperative upper gastrointestinal tract endoscopies, appointments in the outpatient clinic and bariatric operations. Most surgeons performed video calls for follow-up appointments instead of meeting the patients in the outpatient clinics. Laparoscopy was still the preferred treatment for surgical emergencies, but a trend towards conservative treatment of acute appendicitis and acute cholecystitis was shown. Rapid preoperative COVID-19 testing availability was poor; therefore, routine screening of emergency bariatric cases was not widely provided. A wide variance occurred regarding precautions and personal protection equipment among the participants.
CONCLUSION
The COVID-19 pandemic showed a strong impact on bariatric surgical practice regarding surgical and outpatient planning as well as personnel management. Coordinated effort from the national bariatric societies should focus on strict implementation of the current recommendations regarding precaution measures and personal protection equipment. Further studies should evaluate how this impact will evolve in the near future.

Identifiants

pubmed: 32654018
doi: 10.1007/s11695-020-04830-8
pii: 10.1007/s11695-020-04830-8
pmc: PMC7352090
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4428-4436

Investigateurs

Patrick Noel (P)
Rishi Singhal (R)
Matthieu Girodet (M)
Antoine Soprani (A)
Olivier Brehant (O)
David Moszkowicz (D)
Xaviera Coueffe (X)
Jean Sebastien Lanne (JS)
Ilan Rosenblum (I)
Radu Moldovanu (R)
Hannah Pflieger (H)
Cyrille Kuperas (C)
Pedro Martinez Duartez (P)
Misha D P Luyer (MDP)
Laurent Arnalsteen (L)
Eric J Hazebroek (EJ)
Martin Sykora (M)
Colleen Kennedy (C)
Fabian Hauswirth (F)
Riad Tchanderli-Braham (R)
Sébastien Le Page (S)
Evert-Jan G Boerma (EG)
Elias Chousleb (E)
Barbara Langenhoff (B)
Mohamad Hayssam ElFawal (MH)
Luca Paolino (L)
Francesco Martini (F)
Hubert Johanet (H)
Thierry Barthes (T)
Maen Halabi (M)
Marco Del Prete (M)
Felipe Eduardo Fiolo (FE)
Claire Blanchard (C)
Ahmad Bashir (A)
Monika Hagen (M)
Ajjana Techagumpuch (A)
Sebastien Dan (S)
Jean-Marc Catheline (JM)
Constantin Georgeac (C)
Liviu Paul Lefter (LP)
David Lechaux (D)
Jeannette Widmer (J)
Mirjam Anna Kaijser (MA)
Michal Orlowski (M)
Peter François (P)
Ann M Rogers (AM)
Valentin Nitu (V)
Stephane Servajean (S)
Michael Fishman (M)
Dana Mihaela Ignat (DM)
Jean Marie Molasoko (JM)
Marijn Takkenberg (M)
Ennassih Amal (E)
Mazen Charara (M)
Chetan Parmar (C)
Christophe Brévart (C)
Eivind Andreas Warberg (EA)
Ludovic Marx (L)
Michel Vix (M)

Références

Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
Obes Surg. 2020 Jun;30(6):2071-2073
pubmed: 32291701
BMJ. 2020 Mar 18;368:m1106
pubmed: 32188602
Br J Surg. 2020 Jun;107(7):e188
pubmed: 32343368
Nat Rev Endocrinol. 2020 Jun;16(6):297-298
pubmed: 32242089
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352
Br J Surg. 2020 Jun;107(7):785-787
pubmed: 32191340
Surg Endosc. 2020 Jun;34(6):2327-2331
pubmed: 32323016
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
Colorectal Dis. 2020 Jun;22(6):641-642
pubmed: 32227609
Lancet. 2020 May 16;395(10236):1544-1545
pubmed: 32380044
Obes Surg. 2020 Sep;30(9):3624-3627
pubmed: 32314249
J Craniomaxillofac Surg. 2020 May;48(5):521-526
pubmed: 32303420

Auteurs

Ioannis I Lazaridis (II)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Marko Kraljević (M)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Romano Schneider (R)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Jennifer M Klasen (JM)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Dimitrios Schizas (D)

First Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Ralph Peterli (R)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Lilian Kow (L)

Adelaide Bariatric Centre, Flinders Private Hospital, Bedford Park, Adelaide, South Australia, Australia.

Tarik Delko (T)

Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland. tarik.delko@clarunis.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH